164 related articles for article (PubMed ID: 3435698)
1. Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.
Durrant LG; Garnett MC; Gallego J; Armitage NC; Ballantyne KC; Marksman RA; Hardcastle JD; Baldwin RW
Br J Cancer; 1987 Dec; 56(6):722-6. PubMed ID: 3435698
[TBL] [Abstract][Full Text] [Related]
2. Imaging of primary and metastatic colorectal carcinoma with monoclonal antibody 791T/36 and the therapeutic potential of antibody-drug conjugates.
Pimm MV; Armitage NC; Ballantyne K; Baldwin RW; Perkins AC; Durrant LG; Garnett MC; Hardcastle JD
Cancer Detect Prev Suppl; 1987; 1():249-62. PubMed ID: 3480055
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
Affleck K; Embleton MJ
Br J Cancer; 1992 Jun; 65(6):838-44. PubMed ID: 1616855
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution of a monoclonal antibody-methotrexate conjugate (791T/36-MTX) in patients with colorectal cancer.
Ballantyne KC; Perkins AC; Pimm MV; Garnett MC; Clegg JA; Armitage NC; Baldwin RW; Hardcastle JD
Int J Cancer Suppl; 1988; 2():103-8. PubMed ID: 3162436
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies for radioimmunodetection of tumours and for targeting.
Baldwin RW; Embleton MJ; Pimm MV
Bull Cancer; 1983; 70(2):132-6. PubMed ID: 6575842
[TBL] [Abstract][Full Text] [Related]
6. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
7. Preparation of four daunomycin-monoclonal antibody 791T/36 conjugates with anti-tumour activity.
Gallego J; Price MR; Baldwin RW
Int J Cancer; 1984 Jun; 33(6):737-44. PubMed ID: 6376376
[TBL] [Abstract][Full Text] [Related]
8. A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.
Pimm MV; Robins RA; Embleton MJ; Jacobs E; Markham AJ; Charleston A; Baldwin RW
Br J Cancer; 1990 Apr; 61(4):508-13. PubMed ID: 2331436
[TBL] [Abstract][Full Text] [Related]
9. Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates.
Dillman RO; Johnson DE; Ogden J; Beidler D
Mol Biother; 1989; 1(5):250-5. PubMed ID: 2515870
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW
Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo cytotoxic activity of anti-human leukemia monoclonal antibodies SN5c and SN6 daunorubicin conjugates.
Biddle WC; Haruta Y; Seon BK; Henderson ES; Sarcione EJ
Leuk Res; 1989; 13(8):699-707. PubMed ID: 2529399
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and selectivity of monoclonal-antibody-targeted drugs and free methotrexate in fluorescence-labelled mixed tumour-cell monolayer cultures and multicellular spheroids.
Embleton MJ; Charleston A; Affleck K
Int J Cancer; 1991 Oct; 49(4):566-72. PubMed ID: 1917158
[TBL] [Abstract][Full Text] [Related]
13. Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody-directed cytotoxicity in vitro.
Garnett MC; Embleton MJ; Jacobs E; Baldwin RW
Int J Cancer; 1983 May; 31(5):661-70. PubMed ID: 6852982
[TBL] [Abstract][Full Text] [Related]
14. An improved synthesis of a methotrexate-albumin-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines.
Garnett MC; Baldwin RW
Cancer Res; 1986 May; 46(5):2407-12. PubMed ID: 3457627
[TBL] [Abstract][Full Text] [Related]
15. Targeted anti-tumor agents and their cytotoxicity on gastric cancer cells in vitro.
Li S; Zhang XY; Chen XT; Fan DM; Tan LS; Pan HZ; Huang LQ
Chin Med J (Engl); 1990 May; 103(5):376-9. PubMed ID: 2118053
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma.
Takahashi T; Yamaguchi T; Kitamura K; Suzuyama H; Honda M; Yokota T; Kotanagi H; Takahashi M; Hashimoto Y
Cancer; 1988 Mar; 61(5):881-8. PubMed ID: 2962733
[TBL] [Abstract][Full Text] [Related]
17. Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
Embleton MJ; Garnett MC; Jacobs E; Baldwin RW
Br J Cancer; 1984 May; 49(5):559-65. PubMed ID: 6586198
[TBL] [Abstract][Full Text] [Related]
18. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
19. Conjugates of monoclonal antibody 791T/36 with methotrexate in cancer therapy.
Baldwin RW; Embleton MJ; Garnett MC; Pimm MV
NCI Monogr; 1987; (3):95-9. PubMed ID: 3469528
[TBL] [Abstract][Full Text] [Related]
20. Unsuitability of monoclonal antibodies to oncogene proteins for anti-tumour drug-targeting.
Embleton MJ; Habib NA; Garnett MC; Wood C
Int J Cancer; 1986 Dec; 38(6):821-7. PubMed ID: 3539823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
